INTRODUCTION: Limited evidence suggests that focal neurological injury (e.g., acute flaccid paralysis) caused by infection with the West Nile virus (WNV) is more common in older patients. We re-evaluate this association in a series of patients who were infected with the WNV during the 2002 epidemic. METHODS: We performed a retrospective chart review of 34 patients who were hospitalized for treatment of serologically confirmed WNV infection. Measurements included the patient's demographic characteristics, baseline medical diagnoses, the occurrence of symptoms and exam findings, the results of various diagnostic tests, and the patient's clinical outcome. RESULTS: Patients infected with the WNV who developed focal neurological injury were found to be comparable to patients who did not develop focal neurological injury both in terms of patient age and the number of medical conditions the patient had prior to infection. This is in contrast to WNV-infected patients who developed an encephalitis-like clinical course, or who died or were institutionalized after their hospitalization; such patients tended to be older and-in cases with a poor outcome-have more medical conditions prior to WNV infection. CONCLUSIONS: In our patient group, focal neurological injury caused by WNV infection was not related to advanced patient age or to the number of medical conditions the patient had prior to infection. Our findings bring into question commonly held views about the development of focal neurological injury caused by WNV infection, and they raise concerns about the management of future WNV epidemics and the testing and use of potential antiviral treatments against this infection.
INTRODUCTION: Limited evidence suggests that focal neurological injury (e.g., acute flaccid paralysis) caused by infection with the West Nile virus (WNV) is more common in older patients. We re-evaluate this association in a series of patients who were infected with the WNV during the 2002 epidemic. METHODS: We performed a retrospective chart review of 34 patients who were hospitalized for treatment of serologically confirmed WNV infection. Measurements included the patient's demographic characteristics, baseline medical diagnoses, the occurrence of symptoms and exam findings, the results of various diagnostic tests, and the patient's clinical outcome. RESULTS:Patients infected with the WNV who developed focal neurological injury were found to be comparable to patients who did not develop focal neurological injury both in terms of patient age and the number of medical conditions the patient had prior to infection. This is in contrast to WNV-infectedpatients who developed an encephalitis-like clinical course, or who died or were institutionalized after their hospitalization; such patients tended to be older and-in cases with a poor outcome-have more medical conditions prior to WNV infection. CONCLUSIONS: In our patient group, focal neurological injury caused by WNV infection was not related to advanced patient age or to the number of medical conditions the patient had prior to infection. Our findings bring into question commonly held views about the development of focal neurological injury caused by WNV infection, and they raise concerns about the management of future WNV epidemics and the testing and use of potential antiviral treatments against this infection.
Authors: D Nash; F Mostashari; A Fine; J Miller; D O'Leary; K Murray; A Huang; A Rosenberg; A Greenberg; M Sherman; S Wong; M Layton Journal: N Engl J Med Date: 2001-06-14 Impact factor: 91.245
Authors: James J Sejvar; Maryam B Haddad; Bruce C Tierney; Grant L Campbell; Anthony A Marfin; Jay A Van Gerpen; Aaron Fleischauer; A Arturo Leis; Dobrivoje S Stokic; Lyle R Petersen Journal: JAMA Date: 2003-07-23 Impact factor: 56.272
Authors: A E Platonov; G A Shipulin; O Y Shipulina; E N Tyutyunnik; T I Frolochkina; R S Lanciotti; S Yazyshina; O V Platonova; I L Obukhov; A N Zhukov; Y Y Vengerov; V I Pokrovskii Journal: Emerg Infect Dis Date: 2001 Jan-Feb Impact factor: 6.883
Authors: M Y Chowers; R Lang; F Nassar; D Ben-David; M Giladi; E Rubinshtein; A Itzhaki; J Mishal; Y Siegman-Igra; R Kitzes; N Pick; Z Landau; D Wolf; H Bin; E Mendelson; S D Pitlik; M Weinberger Journal: Emerg Infect Dis Date: 2001 Jul-Aug Impact factor: 6.883
Authors: M Weinberger; S D Pitlik; D Gandacu; R Lang; F Nassar; D Ben David; E Rubinstein; A Izthaki; J Mishal; R Kitzes; Y Siegman-Igra; M Giladi; N Pick; E Mendelson; H Bin; T Shohat Journal: Emerg Infect Dis Date: 2001 Jul-Aug Impact factor: 6.883
Authors: John D Morrey; Venkatraman Siddharthan; Hong Wang; Jeffery O Hall; Ramona T Skirpstunas; Aaron L Olsen; Jeffrey L Nordstrom; Scott Koenig; Syd Johnson; Michael S Diamond Journal: J Neurovirol Date: 2008-04 Impact factor: 2.643
Authors: Jennie Johnstone; Steven E Hanna; Lindsay E Nicolle; Michael A Drebot; Binod Neupane; James B Mahony; Mark B Loeb Journal: J Med Case Rep Date: 2011-08-19
Authors: John Hart; Gail Tillman; Michael A Kraut; Hsueh-Sheng Chiang; Jeremy F Strain; Yufeng Li; Amy G Agrawal; Penny Jester; John W Gnann; Richard J Whitley Journal: BMC Infect Dis Date: 2014-05-09 Impact factor: 3.090